Literature DB >> 23088167

Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Gülşen Özkaya Şahin1, Fredrik Månsson, Angelica A Palm, Elzbieta Vincic, Zacarias da Silva, Patrik Medstrand, Hans Norrgren, Eva Maria Fenyö, Marianne Jansson.   

Abstract

Human immunodeficiency virus type 2 (HIV-2) is less transmissible and less pathogenic compared to HIV-1 and, when matched for CD4(+) T cell count, the plasma viral load in HIV-2-infected individuals is approximately one log lower than in HIV-1-infected individuals. The explanation for these observations is elusive, but differences in virus controlling immunity generated in the two infections may be contributing factors. In the present study, we investigated neutralization by immunoglobulin A (IgA), in parallel with IgG, purified from plasma of HIV-1, HIV-2, and HIV-1/HIV-2 dually (HIV-D) infected individuals. Neutralization was analyzed against HIV-1 and HIV-2 isolates using a plaque reduction assay. In HIV-2 infection, intratype-specific neutralization by IgA was frequently detected, although at a lesser magnitude then the corresponding IgG neutralizing titers. In contrast, neutralization by IgA could rarely be demonstrated in HIV-1 infection despite similar plasma IgA levels in both infections. In addition, IgA and IgG of HIV-D plasma neutralized the HIV-2 isolate more potently than the HIV-1 isolate, suggesting that the difference between neutralizing activity of plasma IgA and IgG depends on the virus itself. Taken together, these findings suggest that both IgA and IgG add to the potent intratype neutralizing activity detected in HIV-2 plasma, which may contribute to virus control in HIV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088167      PMCID: PMC3581020          DOI: 10.1089/AID.2012.0219

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  56 in total

1.  HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization.

Authors: 
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

2.  Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.

Authors:  H M Wolf; I Hauber; H Gulle; A Samstag; M B Fischer; R U Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1996-09       Impact factor: 4.330

3.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast.

Authors:  G Adjorlolo-Johnson; K M De Cock; E Ekpini; K M Vetter; T Sibailly; K Brattegaard; D Yavo; R Doorly; J P Whitaker; L Kestens
Journal:  JAMA       Date:  1994-08-10       Impact factor: 56.272

5.  Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection.

Authors:  S Chollet-Martin; F Simon; S Matheron; C A Joseph; C Elbim; M A Gougerot-Pocidalo
Journal:  AIDS       Date:  1994-07       Impact factor: 4.177

6.  A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa.

Authors:  K Ariyoshi; N Berry; A Wilkins; D Ricard; P Aaby; A Nauclér; P T Ngom; O Jobe; S Jaffar; F Dias; R S Tedder; H Whittle
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

7.  Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.

Authors:  P A Kozlowski; D Chen; J H Eldridge; S Jackson
Journal:  AIDS Res Hum Retroviruses       Date:  1994-07       Impact factor: 2.205

8.  Is there IgA of gut mucosal origin in the serum of HIV1 infected patients?

Authors:  A Quesnel; P Moja; F Lucht; J L Touraine; B Pozzetto; C Genin
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

9.  Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees.

Authors:  Z R Israel; P A Marx
Journal:  J Med Primatol       Date:  1995-02       Impact factor: 0.667

10.  CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

Authors:  M J Endres; P R Clapham; M Marsh; M Ahuja; J D Turner; A McKnight; J F Thomas; B Stoebenau-Haggarty; S Choe; P J Vance; T N Wells; C A Power; S S Sutterwala; R W Doms; N R Landau; J A Hoxie
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

View more
  8 in total

Review 1.  Engineering broadly neutralizing antibodies for HIV prevention and therapy.

Authors:  Casey K Hua; Margaret E Ackerman
Journal:  Adv Drug Deliv Rev       Date:  2016-01-29       Impact factor: 15.470

2.  Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.

Authors:  Susanna M Bächle; David F G Malone; Marcus Buggert; Annika C Karlsson; Per-Erik Isberg; Antonio J Biague; Hans Norrgren; Patrik Medstrand; Markus Moll; Johan K Sandberg; Marianne Jansson
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

Review 3.  HIV-2 as a model to identify a functional HIV cure.

Authors:  Joakim Esbjörnsson; Marianne Jansson; Sanne Jespersen; Fredrik Månsson; Bo L Hønge; Jacob Lindman; Candida Medina; Zacarias J da Silva; Hans Norrgren; Patrik Medstrand; Sarah L Rowland-Jones; Christian Wejse
Journal:  AIDS Res Ther       Date:  2019-09-05       Impact factor: 2.250

4.  Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.

Authors:  Lydia Scharf; Christina B Pedersen; Emil Johansson; Jacob Lindman; Lars R Olsen; Marcus Buggert; Sten Wilhelmson; Fredrik Månsson; Joakim Esbjörnsson; Antonio Biague; Patrik Medstrand; Hans Norrgren; Annika C Karlsson; Marianne Jansson
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

5.  Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection.

Authors:  Emil Johansson; Priscilla F Kerkman; Lydia Scharf; Jacob Lindman; Zsófia I Szojka; Fredrik Månsson; Antonio Biague; Patrik Medstrand; Hans Norrgren; Marcus Buggert; Annika C Karlsson; Mattias N E Forsell; Joakim Esbjörnsson; Marianne Jansson
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

6.  CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.

Authors:  Marcus Buggert; Juliet Frederiksen; Ole Lund; Michael R Betts; Antonio Biague; Morten Nielsen; Johanna Tauriainen; Hans Norrgren; Patrik Medstrand; Annika C Karlsson; Marianne Jansson
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

7.  The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau.

Authors:  Jacob Lindman; Mamadu Aliu Djalo; Ansu Biai; Fredrik Månsson; Joakim Esbjörnsson; Marianne Jansson; Patrik Medstrand; Hans Norrgren
Journal:  AIDS Res Ther       Date:  2020-06-12       Impact factor: 2.250

Review 8.  HIV treatment in Guinea-Bissau: room for improvement and time for new treatment options.

Authors:  S Jespersen; F Månsson; J Lindman; C Wejse; C Medina; Z J da Silva; DdS Te; P Medstrand; J Esbjörnsson; B L Hønge
Journal:  AIDS Res Ther       Date:  2020-02-04       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.